- Acumen Powered by Robins Kaplan LLP®
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 17, 2024Emily Tremblay Named IP Rising Star by Euromoney in 2024 Women in Business Law Awards
-
June 17, 2024Three Robins Kaplan Partners Named BTI Client Service All-Stars
-
June 13, 2024Brendan Johnson Named South Dakota Trial Lawyer of The Year
-
June 27, 2024Sex Abuse Litigation
-
June 10-11, 20242024 Probate and Trust Law Section Conference
-
June 11, 2024FBA 2024 Federal Practice Seminar
-
June 2024Robins Kaplan Secures Landmark $7.75 Million Verdict in Aerosol Duster Misuse Case
-
June 2024To Seize or Not to Seize: Campus Protests and Police Uses of Force
-
June 2024Communicating Your Estate Plan: A Helpful Tool, Not a Fix-All
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Allergan Sales, LLC v. Teva Pharms. USA, Inc.
Upholding recommendation for summary judgment because water was not a “gelling agent” in the context of the patent-in-suit.
October 24, 2017
![GENERICally Speaking: A Hatch Waxman Litigation Bulletin](/-/media/images/newsletters/generically-speaking-social-graphics/generically-speaking-nwsltr-badge.jpg?la=en&h=160&w=390&la=en&hash=314B8432ED62E0647D7FC4565EC18B79)
Case Name: Allergan Sales, LLC v. Teva Pharms. USA, Inc., Civ. No. 2:15-cv-1471-JRG-RSP (Lead), 2017 U.S. Dist. LEXIS 176262 (E.D. Tex. Oct. 24, 2017) (Gilstrap, J.)
Drug Product and Patent(s)-in-Suit: Delzicol® (mesalamine); U.S. Patent No. 6,649,180 (“the ’180 patent”)
Nature of the Case and Issue(s) Presented: The parties submitted claim construction briefing seeking construction of the term “gelling agent.” The magistrate judge construed “gelling agent” as having its plain and ordinary meaning, “a substance that gels the film composition,” then concluded that water could not act as a gelling agent. Based on this construction, the magistrate judge recommended granting Teva’s motion for summary judgment for non-infringement. Allergen objected, but the Article III judge overruled those objections and adopted the magistrate’s conclusions.
Why Teva Prevailed: Teva submitted persuasive expert evidence that water could not function as a gelling agent. Instead, water simply served a passive, not active, role in gelling. Further, there was inventor testimony that water was not a gelling agent. In contrast, Allergen was unable to produce any evidence that water gels the composition of the products at issue in the lawsuit. Accordingly, even with the disputed facts all construed in Allergen’s favor, no reasonable person would find that water serves as a gelling agent. For this reason, the court adopted the magistrate’s recommendation and granted Teva’s motion for summary judgment.
Related Professionals
Miles A. Finn, Ph.D.
Counsel
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.